<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37406842</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1519</ISSN><JournalIssue CitedMedium="Internet"><Volume>315</Volume><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Respiratory physiology &amp; neurobiology</Title><ISOAbbreviation>Respir Physiol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Pulmonary recovery directly after COVID-19 and in Long-COVID.</ArticleTitle><Pagination><StartPage>104112</StartPage><MedlinePgn>104112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resp.2023.104112</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1569-9048(23)00100-3</ELocationID><Abstract><AbstractText>Permanent impairment in patients after SARS-CoV-2 infection is frequent, but neither pathophysiology nor mechanisms of the so-called Post-COVID-Syndrome (Long-COVID) are well understood. We present data on pulmonary impairment, pulmonary recovery and outcome comparing patients admitted to a specific COVID-19 rehabilitation program directly after COVID-19 infection with patients long after COVID-19 infection. Diagnostic work up included echocardiography, cardiopulmonary exercise testing and pleural sonography. The rehabilitation program included multimodal respiratory therapy, endurance and resistance muscular training, psychological assistance, and educational measures. Patients in both groups showed similar pulmonary problems. Diaphragm dysfunction was common in both groups. Cardiopulmonary exercise testing showed dysfunctional breathing in most patients of both groups. The specific rehabilitation program applied yielded marked improvements with satisfying pulmonary recovery in both groups. Return to work was possible or expected in most patients. In conclusion, directly after COVID-19 infection as well as in long Covid 4-20&#xa0;months after COVID-19 dysfunctional breathing patterns in cardiopulmonary exercise testing and diaphragm dysfunction on ultrasound are common and need diagnostic awareness and therapy measures. Specialized rehabilitation programs directly after COVID-19 as well as for Long-COVID patients are effective therapeutic options.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Altmann</LastName><ForeName>Christoph H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Herz-Kreislauf-Erkrankungen, MEDIAN Klinik Bad Gottleuba, K&#xf6;nigstra&#xdf;e 39, 01816 Bad Gottleuba, Germany. Electronic address: christoph.altmann@median-kliniken.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zvonova</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Herz-Kreislauf-Erkrankungen, MEDIAN Klinik Bad Gottleuba, K&#xf6;nigstra&#xdf;e 39, 01816 Bad Gottleuba, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Lutz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dozent Anatomie Sportphysiologie, Medischulen Ost, Staatlich anerkannte Schule f&#xfc;r Physiotherapie, Schillerstra&#xdf;e 7, 02763 Zittau, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xfc;ller</LastName><ForeName>Per O</ForeName><Initials>PO</Initials><AffiliationInfo><Affiliation>&#xc4;rztlicher Dienst Kardiologie und Pneumologie, MEDIAN Klinik Flechtingen, Parkstra&#xdf;e 1, 39345 Flechtingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Respir Physiol Neurobiol</MedlineTA><NlmUniqueID>101140022</NlmUniqueID><ISSNLinking>1569-9048</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CPET</Keyword><Keyword MajorTopicYN="N">Diaphragm dysfunction</Keyword><Keyword MajorTopicYN="N">Dysfunctional breathing</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest C. Altmann declares having received fees for consultancies, presentations, congresses, expert testimony, research or other funding from the Companies Pfizer, Amgen, Amarin, Novartis. P Sch&#xfc;ller declares having received fees for consultancies, presentations, congresses, expert testimony, research or other funding from the Companies Pfizer, Amgen, Amarin, Novartis. E Zvonova and L Richter declare no potential competing interests. None of the authors declare any potential competing interests with regard to the work published here.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37406842</ArticleId><ArticleId IdType="doi">10.1016/j.resp.2023.104112</ArticleId><ArticleId IdType="pii">S1569-9048(23)00100-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>